Quantitative Systematic Strategies LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Quantitative Systematic Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$9.83 - $13.99 $107,245 - $152,630	-10,910 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$6.75 - $12.89 $73,642 - $140,629	10,910 New	10,910 $132,000
Q1 2020 May 06, 2020	SELL	$5.8 - $18.56 $73,880 - $236,417	-12,738 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$10.31 - $17.81 $131,328 - $226,863	12,738 New	12,738 $227,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $248M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.